CRYO CELL INTERNATIONAL INC Quarterly Debt-to-equity in % from Q3 2016 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Cryo Cell International Inc quarterly Debt-to-equity history and growth rate from Q3 2016 to Q3 2024.
  • Cryo Cell International Inc Debt-to-equity for the quarter ending August 31, 2024 was -696 %, a 92.1% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 -696 +8.14K +92.1% Aug 31, 2024
Q2 2024 -895 +4.09K +82.1% May 31, 2024
Q1 2024 -1.28K +132K +99% Feb 29, 2024
Q4 2023 -2.21K -7.2K -144% Nov 30, 2023
Q3 2023 -8.83K -11K -507% Aug 31, 2023
Q2 2023 -4.99K -6.19K -514% May 31, 2023
Q1 2023 -133K -134K -10722% Feb 28, 2023
Q4 2022 4.99K +2.58K +107% Nov 30, 2022
Q3 2022 2.17K -3.79K -63.6% Aug 31, 2022
Q2 2022 1.21K +7.09K May 31, 2022
Q1 2022 1.25K +3.15K Feb 28, 2022
Q4 2021 2.41K +3.53K Nov 30, 2021
Q3 2021 5.96K +6.87K Aug 31, 2021
Q2 2021 -5.89K -5.09K -636% May 31, 2021
Q1 2021 -1.9K -1.19K -168% Feb 28, 2021
Q4 2020 -1.12K -460 -69.9% Nov 30, 2020
Q3 2020 -905 -282 -45.2% Aug 31, 2020
Q2 2020 -800 -217 -37.3% May 31, 2020
Q1 2020 -708 -242 -51.8% Feb 29, 2020
Q4 2019 -659 -285 -76.3% Nov 30, 2019
Q3 2019 -623 -305 -96% Aug 31, 2019
Q2 2019 -582 -318 -120% May 31, 2019
Q1 2019 -467 -205 -78.3% Feb 28, 2019
Q4 2018 -374 -117 -45.9% Nov 30, 2018
Q3 2018 -318 -77.1 -32% Aug 31, 2018
Q2 2018 -264 -38 -16.8% May 31, 2018
Q1 2018 -262 -12.8 -5.16% Feb 28, 2018
Q4 2017 -256 +24.8 +8.83% Nov 30, 2017
Q3 2017 -241 +99.3 +29.2% Aug 31, 2017
Q2 2017 -226 May 31, 2017
Q1 2017 -249 Feb 28, 2017
Q4 2016 -281 Nov 30, 2016
Q3 2016 -340 Aug 31, 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.